Trial Information

Summary: A clinical study to determine the safety and efficacy of an experimental drug in hyperuricemic patients with symptomatic gout

Mount Sinai School of Medicine is recruiting hyperuricemic patients with symptomatic gout to participate in a clinical study to test the safety and efficacy of an experimental drug.

You may be eligible to participate in this study if you:

• Are male or female at least 18 years of age
• Are hyperuricemic
• Have symptomatic gout
• Either can’t undergo conventional therapy or conventional therapy has been ineffective

You may not participate in this study if you:

• Have certain types of heart conditions or heart disease
• Are pregnant or intend to become pregnant or are breast feeding during the study
• Have a history of kidney disease requiring dialysis
• Are an organ transplant recipient
• Have a history of allergic reaction to recombinant protein or pig products
• Have participated in another research study within the last 30 days

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.